Table 2 Comparison between patients with EFT< 5 mm and those ≥ 5 regarding risk factors, NLR and VWF
Items | EFT< 5(n = 25) No. (%) | EFT≥5(n = 35) No. (%) | Test | P value |
|---|---|---|---|---|
Age Mean ± SD | 56.72 ± 5.00 | 61.03 ± 5.61 | t = 3.07 | 0.003* |
Sex: | ||||
Males | 12 (48.0) | 20 (57.1) | χ2 = 0.49 | 0.484 |
Females | 13 (52.0) | 15 (42.9) | ||
Smoking | 5 (20.0) | 14 (40.0) | ||
No | 20 (80.0) | 21 (60.0) | χ2 = 2.70 | 0.101 |
Hypertension | 6 (24.0) | 19 (54.3) | χ2 = 5.50 | |
No hypertension | 19 (76.0) | 16 (45.7) | 0.019* | |
DM | 9 (36.0) | 11 (31.4) | ||
No DM | 16 (64.0) | 24 (68.6) | χ2 = 0.14 | 0.711 |
Hypercholesterolemia: | 3 (12.0) | 23 (65.7) | ||
No | 22 (88.0) | 12 (34.3) | χ2 = 17.14 | < 0.001* |
BMI (≥ 25) | 2 (8.0) | 18 (51.4) | ||
Normal | 23(92.0) | 17 (48.6) | χ2 = 12.38 | < 0.001* |
AF | 2(8.0) | 6 (17.1) | ||
No AF | 23 (92.0) | 29 (82.9) | χ2 = 1.05 | 0.304 |
Carotid stenosis | 4 (16.0) | 11 (24.4) | ||
No | 21 (84.0) | 24 (75.6) | χ2 = 1.85 | 0.174 |
Combined risk | 0 | 6 (17.1) | ||
No | 25 (100.0) | 29 (82.9) | χ2 = 4.76 | 0.029* |
Hyperurecemia | 4 (16.0) | 4 (11.4) | ||
No | 21 (84.0) | 21 (88.6) | χ2 = 0.26 | 0.608 |
VWF:Ag (μml) (Mean ± SD) | 9.95 ± 2.14 | 11.57 ± 2.43 | t = 2.67 | 0.010* |
NLR< 2 | 13 (52.0) | 12 (34.3) | χ2 = 1.88 | 0.170 |
NLR ≥ 2 | 12 (48.0) | 23 (65.7) |